Greg Tourangeau - Jan 26, 2024 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Vice President, Finance
Signature
/s/ Gregory Tourangeau
Stock symbol
FULC
Transactions as of
Jan 26, 2024
Transactions value $
$0
Form type
4
Date filed
1/30/2024, 09:10 PM
Previous filing
May 11, 2023
Next filing
Mar 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +83.8K $0.00 83.8K Jan 26, 2024 Common Stock 83.8K $6.95 Direct F1
transaction FULC Stock Option (right to buy) Award $0 +10K $0.00 10K Jan 26, 2024 Common Stock 10K $6.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on January 26, 2024 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2024, subject to the reporting person's continued service on each such vesting date.
F2 This option was granted on January 26, 2024 and is scheduled to vest in equal yearly installments over two years beginning on the vesting commencement date of January 1, 2024, subject to the reporting person's continued service on each such vesting date.